Evidence map›Paper›PMID 38106185›Full record

ArticlebioRxiv : the preprint server for biology2023

The intrinsically disordered tail of ESCO1 binds DNA in a charge-dependent manner.

Jeffrey R Schoen, Jingrong Chen, Susannah Rankin

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jeffrey R SchoenCell Cycle and Cancer Biology program, Oklahoma Medical Research Foundation, 825 NE 13 St, Oklahoma City, OK 73104.
Jingrong ChenCell Cycle and Cancer Biology program, Oklahoma Medical Research Foundation, 825 NE 13 St, Oklahoma City, OK 73104.
Susannah RankinCell Cycle and Cancer Biology program, Oklahoma Medical Research Foundation, 825 NE 13 St, Oklahoma City, OK 73104.
Oklahoma Medical Research Foundation · US

Funding

Regulation of Chromosome Cohesion during Cell Cycle ProgressionR01GM101250 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI RANKIN, SUSANNAH · 2013 to 2022
$3.2M
Mechanisms of cohesin regulation in vertebratesR35GM149343 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI Susannah Rankin · 2023 to 2026
$1.8M
NIGMS NIH HHS R01 GM101250NIGMS NIH HHS R35 GM149343
6 · The paper itself

Abstract

ESCO1 is an acetyltransferase enzyme that regulates chromosome organization and gene expression. It does this by modifying the Smc3 subunit of the Cohesin complex. Although ESCO1 is enriched at the base of chromatin loops in a Cohesin-dependent manner, precisely how it interacts with chromatin is unknown. Here we show that the basic and intrinsically disordered tail of ESCO1 binds DNA with very high affinity, likely through electrostatic interaction. We show that neutralization of positive residues in the N-tail reduces both DNA binding in vitro and association of the enzyme with chromatin in cells. Additionally, disruption of the chromatin state and charge distribution reduces chromatin bound ESCO1. Strikingly, defects in DNA binding do not affect total SMC3 acetylation or sister chromatid cohesion, suggesting that ESCO1-dependent acetylation can occur independently of direct chromatin association. We conclude that the intrinsically disordered tail of ESCO1 binds DNA with both high affinity and turnover, but surprisingly, ESCO1 catalytic activity occurs independently of direct DNA binding by the enzyme.

Identifiers

PMID38106185
PMCPMC10723360
OpenAlexW4389394135

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.